Mentions:
CELLSEARCH® Circulating Tumor Cell (CTC) System.
Also Creativ Bio.
___
Website:
Menarini Silicon Biosystems is the current owner of the CELLSEARCH® Circulating Tumor Cell (CTC) System.
___
The CELLSEARCH® CTC test works by using magnetic particles to select and count epithelial cells in a 7.5 mL blood sample.
YouTube
___
Disclosures of our 2026 mTNBC abstract:
* Menarini-Silicon Biosystem Other, Consultant who may receive payment and/or Honoraria.
* D. L. Adams,
Creatv MicroTech, Inc. Employment, Stock.
N. E. Buss,
https://www.abstractsonline.com/pp8/#!/21436/...ation/9742
___
Menarini's CELLSEARCH is FDA approved. Creativ's LifeTracDx is pre-clinical / R&D.
Cytodyn/Creativ can, use our current trials to secure Creativ an FDA approval.
But it looks like LifeTracDx & CELLSEARCH are different liquid technologies.
I wonder if these 2 liquid approaches are now a total reasoning as to the outstanding mCRC 1 week results released
So keep an eye out too for CELLSEARCH in our current trials
Maybe a liquid collaboration occuring:
LifeTracDx & CELLSEARCH